Previous transgenic mouse studies demonstrated that the bovine rhodopsin sequence between ؊222 and ؉70 base pairs (bp) contains a minimal promoter, which is sufficient to direct photoreceptor cell-specific expression of a lacZ reporter gene. To more fully define the DNA regulatory elements and protein factors involved in regulating rhodopsin transcription, we have developed an in vitro transcription system derived from bovine retinal nuclear extracts. Retinal extracts, as compared to liver, HeLa, and Drosophila embryonic cell extracts, demonstrated preferential activity for the rhodopsin promoter. A template spanning the bovine rhodopsin upstream region from ؊590 to ؉15 bp showed significant activation relative to the basal activity seen with a TATA box containing ؊38 to ؉15 bp template. Deletion analysis indicated that the region between ؊85 and ؊38 bp contained significant positive regulatory activity. This activity was not observed with HeLa extracts, suggesting that it might be retina-specific. Systematic site-directed mutagenesis of the subregion from ؊64 to ؊38 bp indicated that sequences between ؊60 and ؊58 bp and between ؊48 and ؊40 bp harbor critical elements. The former sequence is part of the binding site for the retina-specific transcription factor Nrl, which has been implicated in rhodopsin regulation. Electrophoretic mobility shift assays showed that the latter sequence (؊48 to ؊40 bp), and flanking DNA, designated Ret 4, is bound by both retina-specific and ubiquitously expressed protein factors. Shift assays with mutant oligomers further defined the putative recognition sequences for these protein factors. Together, our results suggest that multiple promoter elements and transcriptional factors are involved in regulating photoreceptorspecific rhodopsin transcription.
Vertebrate retinal development is a complex and carefully choreographed process involving pattern formation, cell fate determination, cell migration, and cell differentiation (1) . These developmental processes are thought, at least in part, to be mediated by the selective and regulated expression of programs of gene expression within individual differentiating cells. An important goal in the molecular understanding of retinal development is to define the mechanisms regulating these programs of gene expression, with particular attention to the molecular "switches" that determine cell fate and eventually lead to the expression of those genes that define the terminally differentiated state. One approach to this goal is to directly identify molecules that are expressed early during retinal development and then test them for relevant activity (2) (3) (4) . 1 A second approach is to take advantage of genetics to identify potentially important regulatory molecules (5, 6) . A third approach, which is the focus of the work presented here, is to start with genes that are markers of late stages of differentiation and then to work backward studying the upstream molecules that regulate their expression.
Rhodopsin, the visual pigment of rod photoreceptors, provides a useful model system for the study of late-stage photoreceptor cell-specific markers (7, 8) . It consists of a 348-amino acid residue protein moiety, rod opsin, covalently joined through a Schiff-base linkage to the chromophore 11-cis-retinal. Upon photon capture, it undergoes a conformational change, which results in activation of the trimeric GTP-binding protein transducin, and this in turn activates the phototransduction cascade. In addition to its intrinsic biologic importance, rhodopsin is also important because structural mutations in its gene can cause the sight-threatening retinal degeneration retinitis pigmentosa and other retinal diseases (9 -11) , and because understanding of its regulatory mechanisms may be useful in the development of effective retinal gene therapy strategies (12) .
Rhodopsin expression is tightly regulated both spatially and temporally. It is found only in rods, and perhaps pinealocytes (13) (14) (15) . Its mRNA is first detectable late in photoreceptor development, at around the time of outer segment formation (16) . Nuclear run-on experiments indicate that the primary level of regulation is at the transcriptional level (16 -18) . Transgenic studies have identified both a proximal promoter, which determines photoreceptor-cell specific expression (19, 20) , and a more upstream rhodopsin enhancer region (RER), 1 which is responsible for high level expression (21) . A region as small as Ϫ176 to ϩ70 bp, relative to the mRNA start site, has proximal promoter activity. 2 The RER, which is located 1.5-2 kilobase pairs upstream, depending on the species, contains a subregion that is homologous to the 37-bp conserved region in the red/green visual pigment locus control region (22) . Biochemical studies have identified a number of putative DNA regulatory elements upstream of the rhodopsin coding region (8) . The Ret 1 binding site, which was identified on the basis of DNase I footprint analysis of the rat rhodopsin promoter, is located in the proximal promoter region and contains a CAAT-TAG core sequence (23) . (The PCE 1 site, which was defined in the arrestin promoter, is similar to and may be identical to the Ret 1 site (24) .) The Ret 1 site binds to a putative 40-kDa factor, which is developmentally regulated and which has been partially purified (25) . There is a putative binding site for the basic helix-loop-helix transcription factor Mash-1 located just upstream of the Ret 1 site (26) . The proximal promoter region, as shown by yeast one-hybrid analysis, also contains binding sites for the retinoid receptor RXR␥ and for two novel paired-homeodomain proteins. 3 The Ret 2 and Ret 3 sites, which were defined by footprint analysis, are just upstream of the proximal promoter region and in the RER, respectively (25) . An apparent homolog of the Drosophila glass binding element also exists in the RER (27) . Transient expression studies with CV-1 cells and primary chick retinal cultures have implicated the bZIP family member neural retinal leucine zipper protein (Nrl) as a transacting regulator of rhodopsin expression and have identified a sequence within the proximal promoter, located between Ϫ65 and Ϫ58 bp, as an Nrl response element (NRE) (2, 4) . The chick retinal culture experiments also implicated the existence of a regulatory region between Ϫ130 and Ϫ85 bp that was distinct from Ret 1. Table I summarizes the DNA binding sites that have been implicated in rhodopsin regulation and indicates how they were identified.
A potentially complementary approach to the ones cited above for the study of retinal gene expression is the use of in vitro transcription. Although most commonly used in conjunction with protein purification to study "simple" model systems in great detail (28 -31) , in vitro transcription systems have also been utilized to analyze complex tissue-specific promoters (32) (33) (34) (35) (36) (37) (38) (39) . However, the only report of the use of in vitro transcription to study retinal gene expression involves the use of a rat brainderived nuclear extract to study S-antigen regulation (40) . To study retina-specific genes, it would clearly be desirable to develop a retina-based in vitro transcription that shows specificity for retinal genes. In this paper we describe the development of such a system using bovine retinal nuclear extracts, prepared by modification of the procedure described by Gorski et al. for rat liver (32) . We also describe the use of this system to further define the bovine rhodopsin promoter, showing that sequences between Ϫ85 and Ϫ38 bp, and particularly between Ϫ61 and Ϫ38 bp, contain positive regulatory elements and provide biochemical evidence that some of these elements are recognized by both retina-specific and ubiquitously expressed proteins.
MATERIALS AND METHODS
Preparation of Nuclear Extracts-Nuclear extracts from bovine retina and other bovine tissues were prepared essentially by the method of Gorski et al. (32) , with modifications as described previously (21) . HeLa cell and Drosophila embryonic cell nuclear extracts were prepared by published procedures (41, 42) . Rat liver nuclear extract was a kind gift from Dr. Joan W. Conaway (Oklahoma Medical Research Foundation, Oklahoma City, OK).
In Vitro Transcription Reactions-In vitro transcription reactions were assayed by either primer extension or G-free cassette analysis. For primer extension, transcription reactions were carried out in a total volume of 25 l containing 20 mM HEPES, pH 7.6, 40 -50 mM KCl, 4 mM MgCl 2 , 0.05 mM EDTA, 0.5 mM dithiothreitol, 8% glycerol, 20 units of RNasin (Promega), 0.4 mM each of the ribonucleoside triphosphates, and 0.1-1 g of DNA template. Reactions were initiated by the addition of 45-100 g of nuclear extract, incubated at 30°C for 1 h, and terminated by the addition of 100 l of stop solution (20 mM EDTA, 200 mM NaCl, 1% (w/v) SDS, 0.25 mg/ml yeast total RNA, and 0.125 mg/ml proteinase K). After 4 min at room temperature, 300 l of 0.3 M NaOAc was added, and then the mixture was phenol-chloroform-extracted, chloroform-extracted, and ethanol-precipitated. The pellet was resuspended in 100 l of 0.3 M NaOAc, ethanol-precipitated again, washed with 75% ethanol, and vacuum dried.
Primer extension was carried out with a primer, corresponding to the bovine rhodopsin sequence from bp 130 to 112, or a pAdML extension oligomer, corresponding to adenovirus major late (AdML) sequence from bp 93 to 75. The RNA pellet was resuspended in 10 l of annealing buffer (2 mM Tris⅐Cl, pH 7.8, 0.2 mM EDTA, and 0.25 M KCl) and 1 l of the appropriate 32 P-end-labeled primer (about 25-50 fmol, 4 -10 kcpm). The mixture was heated to 75°C for 2 min and slowly cooled to 37°C. Primer extension was initiated by addition of 40 l of extension mix (50 mM Tris⅐Cl, pH 8.3, 10 mM MgCl 2 , 5 mM dithiothreitol, 100 mg/ml actinomycin D, 0.33 mM each of the deoxyribonucleoside triphosphate, and 1 l of Moloney murine leukemia virus reverse transcriptase (Life Technologies, Inc., 200 units/l) and carried out at 37°C for 1 h. The reaction products were then ethanol-precipitated, washed with 75% ethanol, vacuum dried, and analyzed on a 6% denaturing gel.
For G-free cassette analysis, transcription reactions were performed essentially as just described, except that each reaction contained 0.2-1.2 g of the experimental template and 0.1 g of an internal control AdML template (AdML265/Ϫ404); templates were linearized by restriction enzyme digestion at the 3Ј-end of the G-free cassette; the concentrations of ribonucleoside triphosphates were 0.4 mM ATP and CTP, 16 M UTP, 10 Ci of [␣-
32 P]UTP (3000 Ci/mmol, 10 mCi/ml), and 200 M 3-O-methyl-GTP (Pharmacia Biotech Inc.); and the reactions were terminated by addition of 175 l of stop solution (0.3 M Tris⅐HCl, pH 7.4, 0.3 M NaOAc, 0.5% SDS, 2 mM EDTA, 20 g/ml yeast tRNA, and 0.125 mg/ml proteinase K). The RNA products were phenol-chloroform-extracted, ethanol-precipitated, and analyzed on a 6% denaturing gel. The resulting bands were quantitated by PhosphorImager analysis (Molecular Dynamics). The activity of the experimental templates relative to the AdML internal control was analyzed using StatView 4.0 (Abacus Concepts).
Plasmid Constructs-Bovine rhodopsin G-free templates ( Fig. 2A ) were generated by subcloning appropriate rhodopsin upstream frag-3 S. Chen, Q. Wang, and D. J. Zack, unpublished results. (43) . The rhodopsin fragments were generated by PCR using gBR200 (20) as a template. Each 5Ј primer contained 18 bp corresponding to the appropriate bovine rhodopsin sequence, a 5Ј XhoI site, and an additional 6 bp of 5Ј spacer DNA, except for the 23-bp Ϫ590 primer, which consisted of only the bovine rhodopsin sequence from Ϫ590 to Ϫ567 bp. The 3Ј primer (5Ј-GGTTGGATGATTTGTGGCTCCAACTC-3Ј) used for all the constructs consisted of the complement of the rhodopsin sequence from ϩ15 to Ϫ11 bp, except all C nucleotides (positions ϩ3, ϩ5, ϩ8, and 13, underlined), corresponding to G nucleotides in the RNA, were changed to T nucleotides so as to avoid premature incorporation of 3-O-methyl-GTP into the in vitro synthesized RNA molecules. The PCR products were gel-purified, filled in with Klenow fragment, and subcloned into the SstI site of p(C 2 AT) 19 , which had been previously filled in with Klenow fragment. The resulting recombinant plasmids were sequenced to select for correct insert orientation and to rule out any PCR-induced mutations in the inserts. The internal control template AdML265/Ϫ404, which contains a shortened G-free cassette, was generated by restriction of pAdML(C 2 AT) 19 with SmaI and PstI, digestion with ExoIII (New England Biolabs (NEB), 20 units/g DNA) for 4 min at 6°C, polishing the ends with mung bean nuclease (NEB, 10 units/g DNA) at 30°C for 30 min, and ligation with T4 DNA ligase (NEB). Resulting plasmids were sequenced to confirm the size of the deletion. All templates for in vitro transcription were prepared by double-banding in cesium chloride and were digested with HindIII to linearize the molecules.
Site-directed Mutagenesis-Systematic mutations were introduced into the bovine rhodopsin promoter region between Ϫ64 and Ϫ38 bp in the BR395/Ϫ85 and BR395/Ϫ590 constructs using the Altered Sites II in vitro mutagenesis system according to the manufacturer's instructions (Promega). The bovine rhodopsin G-free fragments were excised from BR395/Ϫ85 and BR395/Ϫ590 by first restricting with EcoRI, filling in with Klenow fragment, and then restricting with BamHI. The resulting gel-purified fragments were then subcloned into BamHI and the blunt-ended SalI sites of the vector pALTER-1 (Promega). Singlestranded DNA template was generated, and mutagenesis was performed according to the protocol provided with the Altered Sites II in vitro mutagenesis system (Promega). Systematic mutagenesis of the region from Ϫ64 to Ϫ38 bp was carried out with 25-bp mutagenic oligonucleotides, which contained 3 central mutated bp surrounded on each side by 11 wild-type bp, except for the Ϫ64 to Ϫ61 bp mutation, which used a 27-bp oligonucleotide containing a central 4 bp mutation, and the Ϫ39 to Ϫ38 bp mutation, which used a 25-bp oligonucleotide containing a central 2-bp mutation. All base changes were T 3 G, G 3 T, A 3 C, or C 3 A transversions. Mutations were verified by sequence analysis.
Electrophoretic Mobility Shift Assays-Gel mobility shift assays were performed essentially as described previously (21) using oligonucleotide pairs PϪ55/Ϫ36 and PϪ55/Ϫ44, which correspond to the rhodopsin region from Ϫ55 to Ϫ36 bp and Ϫ55 to Ϫ44 bp, respectively (Fig. 3C ). Oligonucleotide pairs equivalent to PϪ55/Ϫ36 but containing the same base changes as noted above for mutagenesis were also synthesized. The oligonucleotide pairs were radiolabeled by filling in the ends with [␣- 32 P]dCTP and the three other dNTPs (0.125 mM each) using Klenow fragment. Binding reactions contained approximately 20,000 cpm of 32 P-labeled oligomer, 0.1 g of poly(dI-dC), and variable concentrations of nuclear extract ranging from 0 to 10 g. For the cold oligomer competition experiments, the indicated competitor was incubated with the nuclear extract binding reaction mix on ice for 15 min before addition of the 32 P-labeled probe.
RESULTS

Development of a Bovine Retinal Nuclear Extract in Vitro
Transcription System-Transcriptionally active bovine retina nuclear extracts were generated by modification of the method described by Gorski et al. for the generation of rat liver extracts (32) . As shown by primer extension, DNA templates containing the bovine rhodopsin upstream sequence from Ϫ2174 to ϩ200 bp (relative to the transcription initiation site) yielded correctly initiated RNA transcripts (Fig. 1A, lane 3) that appeared identical to the endogenously synthesized message (lane 1). Promoterless templates showed only minimal background activity, some of which may have been due to low level contamination of the extracts with endogenous rhodopsin mRNA (lane 2). The transcriptional activity of the retinal extracts was RNA polymerase II-dependent, as indicated by sensitivity to inhibition by 4 g/ml ␣-amanitin (lane 4) (44) . In addition, the transcriptional activity was dependent on the presence of a TATA box, as shown by the finding that mutation of the TATA-like sequence TTCATAA (Ϫ31 to Ϫ25 bp) to the sequence TGACGCA resulted in complete loss of transcriptional activity (Fig. 1B) . (Note: in this experiment transcriptional activity was monitored with a G-free cassette rather than by primer extension; see below.)
Retinal Extracts Show Relative Specificity for the Rhodopsin Promoter-The tissue specificity of the retinal extracts was assessed by comparison with extracts from non-retinal cells and tissues. HeLa cell, Drosophila embryonic cell, and retinal extracts all showed activity with a template containing the ubiquitously active AdML promoter (Fig. 1A, lanes 5, 7, and  10) . In contrast, only the retina extract demonstrated significant activity with the rhodopsin promoter (lane 3 versus lanes 6 and 9).
To investigate this relative tissue specificity more quantitatively, further analysis was performed by G-free cassette analysis (43) rather than by primer extension, so as to eliminate background bands due to aberrant initiation events and background due to the variable presence of endogenous rhodopsin mRNA in the retinal nuclear extracts. The G-free cassette templates were named with an abbreviation for the source of the promoter, the length of the cassette itself, and the 5Ј limit of the promoter sequence ( Fig. 2A) . The generation of cassettes with different sizes allowed use of the AdML cassette template (AdML265/Ϫ404) as an internal control. Consistent with the primer extension results, the AdML265/Ϫ404 was active with both the HeLa and retinal extracts, but the rhodopsin template extending from Ϫ590 to ϩ15 bp (BR395/Ϫ590) showed significant activity only with the retinal extract (Fig. 2B) , although occasional batches of HeLa extract with high levels of basal activity did show some activity with BR395/Ϫ590.
Since HeLa cells and the AdML promoter are relatively non-tissue-specific, we also compared the retinal extracts to another tissue-specific in vitro transcription system. Fig. 2C shows the relative abilities of retinal and rat liver extracts to transcribe BR395/Ϫ590 and an albumin promoter template (Alb400/Ϫ170). Under optimal conditions, in which the concentration of template was carefully titered, the retina extract did produce an appropriate size transcript (400 bp) from the Alb400/Ϫ170 template (lanes 4 -6), but the activity was low (barely detectable) as compared to the rhodopsin template (lanes 1-3) . The opposite result was observed with the liver extract, in which the Alb400/Ϫ170 template was efficiently transcribed (lanes 10 -12) , while the rhodopsin template was only minimally transcribed (lanes 7-9) . PhosphorImager quantitation indicated that the relative specificity of the two extracts for the two different templates was greater than 100-fold.
The Bovine Rhodopsin Promoter Region between Ϫ85 and Ϫ38 bp Contains Retina-specific Positive Regulatory Elements-Comparison of the transcriptional activity of the bovine rhodopsin templates BR395/Ϫ590 and BR395/Ϫ38 indicated the presence of positive regulatory elements located between Ϫ590 and Ϫ38 bp (Fig. 2B, lanes 7-12) . To identify these putative elements, a 5Ј deletion analysis of the region between Ϫ590 and Ϫ38 bp was performed and analyzed by PhosphorImager quantitation (Fig. 3) . After correction based on the AdML265/Ϫ404 internal control, there was minimal difference observed between the constructs spanning the region from Ϫ590 to Ϫ85 bp. However, deletion of the sequences between Ϫ85 and Ϫ61 bp and between Ϫ61 and Ϫ38 bp both resulted in significant decreases in transcriptional activity (Fig. 3A) . In order to evaluate the retinal specificity of these putative regu-latory elements, a similar deletion analysis was performed with HeLa extracts. As can be seen, all templates showed essentially the same low level of activity (Fig. 3B) , suggesting that the elements between Ϫ85 and Ϫ61 bp and between Ϫ61 and Ϫ38 bp might act in a retina-specific manner. Fig. 3C shows sequence comparison of the relevant upstream sequences from the cow, human, murine, rat, Chinese hamster, and chick rhodopsin genes. The mammalian genes clearly show a high degree of sequence conservation throughout the region, including the 5Ј-untranslated region. The chick sequence is less conserved but also shows areas of significant homology.
A Positive Regulatory Element, Ret 4, Is Present between Ϫ54 and Ϫ40 bp-To define the DNA sequence(s) responsible for the positive regulatory activity located between Ϫ61 and Ϫ38 bp, systematic site-specific mutagenesis was performed on the BR395/Ϫ85 construct. The entire region between Ϫ61 and Ϫ38 bp, as well as 3 additional 5Ј flanking bp, was altered 2-4 bp at a time (Fig. 4) . The in vitro transcriptional activities of the wild-type and mutant BR395/Ϫ85 templates were then compared (Fig. 4) . All the mutant templates showed decreased activity relative to the wild-type sequence; the decreases ranged from 17% to 65%. Two subregions (Ϫ60 to Ϫ58 bp and Ϫ48 to Ϫ40 bp) showed particularly large decreases, averaging approximately 40% of wild-type activity.
Since the activity of DNA regulatory elements is partially dependent on their context and relationship to other elements, an identical mutation analysis was also performed on the region from Ϫ64 to Ϫ38 bp within the BR395/Ϫ590 construct. The results within the context of the Ϫ590 to ϩ15 bovine rhodopsin upstream region were similar to those with the Ϫ85 to ϩ15 constructs with respect to the Ϫ48 to Ϫ40 bp subregion, but showed less inhibition with the Ϫ60 to Ϫ58 mutant template (data not shown).
The sequence between Ϫ60 and Ϫ58 bp corresponds to part of the NRE site, which has been implicated as a positive regulator of rhodopsin expression (2, 4). 1 The Ϫ48 to Ϫ40 sequence, which is highly conserved between mammalian rhodopsin promoters (Fig. 3C) , has not been previously identified as a regulatory element. Based on the nomenclature previously established by Moribito et al. (23) , we will henceforth refer to the DNA response element containing the sequence Ϫ48 to Ϫ40 bp and flanking DNA as Ret 4. (Based on the EMSA data shown below, we have operationally defined the Ret 4 site as extending from Ϫ54 to Ϫ40 bp.)
Ret 4 Is Recognized by Both Retina-specific and Ubiquitously Expressed Protein
Factors-EMSAs were performed to investigate possible protein-DNA interactions involving Ret 4. EMSA with a 20-bp probe spanning the sequence between Ϫ55 and Ϫ36 bp (GGGAGCTTAGGGAGGGGAGG) and bovine retinal nuclear extract demonstrated three shifted bands, labeled A, B, and C (Fig. 5A, lanes 2-5) . To determine if these bands represented retina-specific protein-DNA interactions, extracts made from cerebral cortex, liver, kidney, and HeLa cells were also tested (lanes 6 -21) . Band A appears to be retina-specific, whereas band C corresponds to a more ubiquitously expressed binding activity. Band B may also be retina-specific, but it is more difficult to assess because it is weak and less distinct.
The sequence specificity of the mobility shifts was assessed using a mutagenesis approach similar to that described above for the in vitro transcription analysis. DNA oligomer probes -8) , and Drosophila embryos (lanes 9 and 10). Transcripts were detected by primer extension. The resulting products were analyzed on a 6% denaturing gel. Lanes 3, 4, 6, and 9 contained 0.8 g of a bovine rhodopsin template spanning the region from Ϫ2174 to ϩ200 bp (relative to the transcription initiation site). Lane 2 contained 0.8 g of the control plasmid pUC118. The running position for the expected 130-nt opsin primer extension product is indicated by the arrow. Lane 1, which serves as a positive control, shows primer extension from 0.5 g of endogenous bovine retinal RNA. spanning the sequence between Ϫ55 and Ϫ36 bp were synthesized in which the region from Ϫ54 to Ϫ38 bp was altered 3 bp at a time, except for the mutant 39 -38 in which only 2 bp were altered. EMSAs with the resulting probes showed significant changes compared to the wild-type probe (Fig. 5B) . Mutations in the sequence between Ϫ54 and Ϫ46 bp eliminated band A, the retina-specific binding activity, but had little affect on the ubiquitously expressed C band binding activity (lanes 6 -16) . In contrast, mutations in the sequence between Ϫ45 and Ϫ38 bp caused complete loss of band C without affecting band A. Therefore, the sequence between Ϫ54 to Ϫ46 seems to be important for determining the retina-specific protein-DNA interactions represented by band A, while the sequence between Ϫ45 to Ϫ38 bp seems to be critical for controlling the ubiquitously expressed protein-DNA interactions represented by band C. It is interesting that, although both sequences are conserved, the sequence required for the retina-specific interactions is more highly conserved than the sequence required for the more ubiquitous interactions (Fig. 3C) .
To confirm and further explore the sequence responsible for the putative retina-specific binding activities, EMSAs were performed with a smaller DNA probe (PϪ55/Ϫ44), spanning the sequence between Ϫ55 and Ϫ44 bp (GGGAGCTTAGGG; Fig. 3C ). Retinal extract demonstrated a single shift band (Fig.  5C, lanes 2-4) , while extracts made from cerebral cortex, liver, kidney, and HeLa cells did not show any detectable binding activity (lanes 5-15) . Fig. 5D shows a competition EMSA in which the ability of cold PϪ55/Ϫ44 to inhibit the A, B, and C bands generated with radiolabeled PϪ55/Ϫ36 was tested. Cold PϪ55/Ϫ36 significantly inhibited all the bands, although band C was only partially inhibited at the concentrations shown (lanes 2-5) . In contrast, and consistent with the mutagenesis EMSA (Fig. 5B ), cold competition with PϪ55/Ϫ44 completely inhibited band A (lanes 6 -9), but it had little effect on bands B and C. DISCUSSION The variety of approaches that have been used to study rhodopsin expression are complementary to each other (8) . However, each by itself is limited. Transgenics studies provide useful functional information, are in vivo, and give detailed information about cell type and temporal specificity (19 -21) . However, quantitative and detailed deletion and mutational analysis is limited by chromosomal position effects and the time and expense involved in such studies. Cell transfection experiments provide a functional assay, which, due to greater speed and reduced cost, is more amenable to detailed deletion and mutational analysis and also allows the use of cotransfection to explore the effects of putative trans-regulators (2, 4). 1 However, for the study of mammalian photoreceptor-specific genes, ideal cell culture systems are not available. Although primary chick retinal cultures mimic many of the properties of their in vivo counterparts and can be efficiently transfected (45) , the mechanisms regulating chick rhodopsin expression are presumably not identical to those regulating mammalian rhodopsin expression and appropriate cell type specificity has not yet been achieved. Mammalian primary retinal cell cultures are also available (46) , but they are difficult to transfect efficiently (2) . Human retinoblastoma cell lines are available and have been used for expression studies (47) (48) (49) , but they are transformed cells, their cell of origin is controversial, and none have been reported to express rhodopsin. In addition, although cultured cells can provide a useful first approximation, there are several reports demonstrating differences between results obtained with transient transfection and the more in vivo transgenic situation (50, 51), perhaps because transiently transfected DNA is not incorporated into chromatin and is FIG. 2 . Retina extracts show relative specificity for rhodopsin templates. A, promoter/G-free cassette DNA templates. The name for each construct is listed on the left. The nomenclature is based on the type of promoter, the length of the G-free cassette, and the 5Ј end of the promoter sequence (relative to the transcription start site). The indicated promoter fragments (BR (bovine rhodopsin), AdML (adenovirus major late), and Alb (mouse albumin)) were fused to the respective G-free cassette (open bars) (43) . B and C, relative opsin specificity of the retinal in vitro transcription system. B, HeLa versus retinal nuclear extracts. BR395/Ϫ590 and BR395/Ϫ38 templates at the indicated concentration (0.2, 0.4, or 0.6 g) were transcribed by HeLa cell or bovine retinal nuclear extract. The positions for the opsin (395 nt) and AdML (265 nt) transcripts are indicated by arrows. C, liver versus retinal nuclear extracts. BR395/Ϫ590 (Opsin) and Alb400/Ϫ170 (Alb) templates were transcribed by bovine retinal and rat liver extracts. have not yet been demonstrated to be functionally significant.
In this paper we have described and demonstrated the utility of a bovine retinal nuclear extract-derived in vitro transcription system, which expands the repertoire of approaches available for the study of retina-specific gene expression. This system, we hope, will help bridge the gap between the biochemical and other more functional assays and will allow analysis of both cis-acting elements and trans-acting factors. The retinal extracts correctly initiate rhodopsin transcription and are both polymerase II-and TATA box-dependent. Compared to HeLa cell, Drosophila embryonic cell, and rat liver nuclear extracts, the retinal system displays relative specificity for rhodopsin templates. The difference in ratio of activity of rhodopsin templates to albumin templates in retinal extracts compared to liver extracts is greater than 100-fold. In addition, HeLa extracts, which show variable and only low level basal activity for the rhodopsin promoter, do not show any response to the positively acting DNA elements defined with the retinal extracts. These results suggest that at least some of the mechanisms responsible for photoreceptor-specific expression of rhodopsin are active in the retinal nuclear extracts.
The finding that the degree of template specificity seen in vitro is not as great as that observed in vivo is common to many in vitro transcription systems, and may be due to several factors. 1) The templates added to the in vitro reaction mixture are naked DNA, not the chromatin that is found in vivo, and chromatin structure has been implicated as being important in gene regulation (54, 55) . Perhaps related to this, the upstream rhodopsin enhancer region does not show activity in the retinal in vitro transcription system. 4 The ongoing development of in vitro systems to generate chromatin-like structures may provide a solution to this problem (56 -58) .
2) The promoter/G-free cassettes used in our assays extended only to bp 15 and, in addition, the four G nucleotides between bp 1 and 15 were mutated so as to prevent premature incorporation of 3-O-methyl-GTP. The strong evolutionary conservation of the mammalian rhodopsin 5Ј-untranslated region (Fig. 3C ) (20) , as well as footprint analysis which demonstrates an extended protected region over the 5Ј-untranslated region, 5 suggest that the bp 1-70 sequence may play an important regulatory role, and its absence may limit the specificity of the system. 3) The retinal extracts are derived from whole retina, which contains multiple cell types, rather than from purified photoreceptor cells. The extracts thus contain factors from non-rod cells, which could interfere with the presumably finely tuned combinatorial array of factors responsible for the cell type-specific expression of rhodopsin. The potential importance of this issue is supported by preliminary data that the retina contains negatively acting factors, perhaps analogous to the neuron-restrictive silencer element (59) , that repress rhodopsin expression in non-photoreceptor cells (53) . 6 4) Some of the important rhodopsin regulatory factors, co-activators, or accessory molecules may be unstable and thus may not be active in the retinal nuclear extracts.
We have used the retinal in vitro transcription system to further map the bovine rhodopsin proximal promoter region. The activity of the Ϫ590 to ϩ15 template was approximately Activity is shown as the ratio of opsin template activity to AdML template activity ϫ 100. The arrow bars represent one standard error of mean. B, deletion analysis using HeLa extracts. Identical deletion analysis as described in A was performed using HeLa nuclear extracts. The PhosphorImager quantitation and its comparison to the results obtained with the retina extracts are shown. C, 5Ј-flanking sequences from the cow, human, mouse, rat, Chinese hamster, and chick rhodopsin genes were aligned using GeneWorks 2.3 software. Outlined regions represent sequences that are identical in all mammalian species. (Where the chick sequence is identical, it is also outlined.) Shaded areas represent regions conserved in at least four of the mammalian species. Positions of the mRNA start site, TATA box, Ret 4, Ret 1, the NRE, and the oligomer probes used for EMSA (PϪ55/Ϫ36 and PϪ55/Ϫ44) are indicated above the alignment. The position(s) of the transcription start site(s) are also underlined. Since the start site of the chick rhodopsin gene has not been determined, it is assumed to be the "C" indicated in the figure based on homology with the mammalian promoters. 10-fold higher than that of the TATA-containing Ϫ38 to ϩ15 template. Deletion analysis revealed that most of the positive regulatory activity in this region resided in the sequence from Ϫ85 to Ϫ38 bp, a sequence that is highly conserved between the mouse, rat, cow, and human rhodopsin genes (Fig. 3C) (20, 23, 60, 61, 62) . This is generally consistent with the transgenic result that a Ϫ176 to ϩ70 bp construct can direct photoreceptor-specific expression. 2 The minimal region required for such activity in transgenics has not yet been defined. Mutation analysis with the in vitro transcription system further defined the sequences between Ϫ60 and Ϫ58 bp and between Ϫ48 and Ϫ40 bp as being particularly important. The Ϫ60 to Ϫ58 bp sequence is part of the binding site for the retina-specific Maf family member Nrl, which has recently been implicated in the regulation of rhodopsin expression (2, 4) . Also consistent with a role for this sequence in mediating Nrl-based transactivation is the finding that in a yeast one-hybrid assay a "bait" sequence containing this region consistently pulls out Nrl (2) .
The Ϫ48 to Ϫ40 bp region, and flanking DNA (Ϫ54 to Ϫ40 bp), which we have named Ret 4, does not match any previously identified regulatory sequence. Efforts are currently under way to identify and clone the DNA-binding proteins that interact with Ret 4. The mobility shifts and competition assays shown in Fig. 5 suggest that both retina-specific and more ubiquitously expressed proteins may be able to interact with Ret 4. The mutation analysis demonstrates that at least some of these interacting proteins demonstrate distinct binding specificities. Although there is good correlation between the in vitro transcription and EMSA data, the correlation is not perfect; the Ϫ48 to Ϫ40 bp region is most critical in the transcription assay, the PϪ55/Ϫ44 oligomer is shifted only by retinal extracts, the retinal-specific DNA-protein interactions are interrupted by mutations in the Ϫ54 to Ϫ46 bp region, and the ubiquitous interactions are interrupted by mutations in the Ϫ38 to Ϫ45 bp region. However, considering the complexity of transcriptional regulation and protein-DNA interaction, the correlation between the functional and biochemical assays seems reasonable.
The in vitro transcription deletion analysis does not demonstrate significant regulatory activity associated with the Ret 1 assays were performed with a 32 P-labeled oligomer pair spanning Ϫ55 to Ϫ36 bp of the bovine rhodopsin gene (PϪ55/Ϫ36, Fig. 3C ), using nuclear extracts made from the indicated tissues. Each lane contained 0.1 g of poly(dI-dC). Lane 1 contained no protein extract, while all other sets of lanes contained 2.5, 5.0, 7.5, and 10 g of nuclear extract, respectively. Lane 22 contained 5.0 g of retinal extract. The sequencespecific protein-DNA interactions are indicated by arrows labeled A, B, and C. B, EMSA with wild-type and mutant PϪ55/Ϫ36 probes. EMSA assays were performed with 32 P-labeled wild-type (WT) or with mutant PϪ55/Ϫ36 oligomer pairs containing mutations at the positions indicated on top of the figure. Each set of lanes for each oligomer pair contained 0, 2.5, 5, and 10 g of retinal extract, respectively, except for lane 22, which contained 5 g. The three bands observed with the wild-type oligomer pair are indicated by the arrows labeled A, B, and C. C, EMSA with PϪ55/Ϫ44 probe. A 32 P-labeled oligomer pair spanning Ϫ55 to Ϫ44 bp of the bovine rhodopsin gene (PϪ55/Ϫ44; Fig. 3C ) was incubated with nuclear extracts made from the indicated tissues. Each lane contained 0.01 g of poly(dI-dC). Lane 1 contained no protein extract. Lanes 14 and 15 contain 2.5 and 5.0 g of HeLa extract, respectively. All other sets of lanes contained 2.5, 5.0, and 10 g of the indicated nuclear extract, respectively. The sequence-specific protein-DNA interaction is indicated by an arrow labeled A. D, EMSA with PϪ55/Ϫ36 and cold competitor oligomers. 32 P-Labeled PϪ55/Ϫ36 was incubated with 6 g of the bovine retinal nuclear extract and 0.1 g of poly(dI-dC), in the absence or presence of the indicated cold competitor oligomers. Lane 1 does not contain any cold competitor. Lanes 2-5 contain the cold competitor oligomer PϪ55/Ϫ36, while lanes 6 -9 contain the cold competitor oligomer PϪ55/Ϫ44. The molar ratios of competitor to labeled oligomer for each set are 10:1, 100:1, 500:1, and 1000:1, respectively. As in A above, bands A, B, and C are indicated by arrows.
FIG. 5.
Ret 4 is recognized by both retina-specific and ubiquitously expressed proteins. A, EMSA with PϪ55/Ϫ36 probe. EMSA binding site. The reason for this lack of activity is unclear. Although the Ret 1 site (see Fig. 3C ) was originally identified by footprint analysis with rat extracts on rat templates (23), a homologous site is present in the bovine rhodopsin upstream region and bovine retinal extracts do protect the region from Ϫ138 to Ϫ126 bp (53) . Perhaps Ret 1, or a necessary associated factor or co-activator, is unstable and thus not functional in the in vitro system. Once it is available in sufficient quantity, it will be interesting to assess the effect of the addition of purified Ret 1 to the retinal extracts. Likewise, once an antibody to Ret 1 is available, it will be interesting to assess the effect of the depletion of Ret 1.
As is true for most cell-type specific promoters, the rhodopsin proximal promoter appears to achieve high level activity and specificity through the synergistic interplay of a number of different DNA binding elements and protein factors. No single site nor factor seems to be able to account for the rhodopsin promoter's high degree of activity and specificity. The bovine retina in vitro transcription system described in this paper will hopefully provide a useful additional approach for identifying and characterizing the elements and factors involved. Ultimately, however, the results obtained from in vitro transcription analysis, such as the identification of Ret 4, will need to be confirmed by cell culture, transgenic, and/or other forms of in vivo analysis.
